AbbVie, Intel, Sony, BCE : Intellectual Property

Updated on

Dec. 2 (Bloomberg) -- AbbVie Inc., the pharmaceutical research company spun off from Abbott Laboratories in 2013, has signed a licensing agreement for two pediatric AIDS treatments with the Medicines Patent Pool.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.